Coeptis Therapeutics Holdings, Inc. - Common Stock (COEP)

CUSIP: 19207A207

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
5,346,236
Total 13F shares
55,239
Share change
+46,735
Total reported value
$517,607
Price per share
$9.37
Number of holders
8
Value change
+$437,923
Number of buys
5
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 19207A207?
CUSIP 19207A207 identifies COEP - Coeptis Therapeutics Holdings, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Coeptis Therapeutics Holdings, Inc. - Common Stock (COEP) as of Q1 2025

As of 31 Mar 2025, Coeptis Therapeutics Holdings, Inc. - Common Stock (COEP) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,239 shares. The largest 9 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Steward Partners Investment Advisory, LLC, Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., BANK OF AMERICA CORP /DE/, Semmax Financial Advisors Inc., and BARCLAYS PLC. This page lists 9 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.